[6]
On the 5th of April, 1993, Novopharm filed a New Drug Submission ("NDS") with the Health Protection Branch ("HPB") of the Department of National Health and Welfare (now the Department of Health) for a Notice of Compliance ("NOC") for 5 mg, 10 mg and 20 mg tablets of enalapril maleate to be made from the 100 kg of bulk enalapril maleate held by it.